Ranbaxy gets approval to market Ran-Rosuvastatin drug in Canada
Quotes

Ranbaxy gets approval to market Ran-Rosuvastatin drug in Canada

Last Updated: Saturday, March 31, 2012, 13:30
 
 Comment 0
 
Ranbaxy gets approval to market Ran-Rosuvastatin drug in Canada
Mumbai: Indian generic drug maker Ranbaxy Laboratories Ltd. said Saturday that its subsidiary in Canada got an approval from Health Canada to manufacture and market Ran-Rosuvastatin tablets, a cholesterol-lowering medication, to the Canadian healthcare system.

Ranbaxy said the approval for this molecule will provide an affordable alternative to the brand Crestor in Canada, which had sales of USD 742.2 million in 2011.

"We anticipate making Rosuvastatin tablets available to all classes of trade after April 2 when sufficient supplies are available to meet market demand," said Paul Drake, president and general manager of Ranbaxy Pharmaceuticals Canada Inc., the subsidiary of Ranbaxy Laboratories.

The finished dosage form will be manufactured within Ranbaxy Laboratories's Health Canada approved facilities located in India, said Drake.

Bureau Report



First Published: Saturday, March 31, 2012, 13:30


Comments


comments powered by Disqus
Renault Kwid
Renault Kwid
Tata GenX Nano
Tata GenX Nano
2015 Indian Roadmaster
2015 Indian Roadmaster
Forbes 2015 Rich List
Forbes 2015 Rich List
Audi TT Coupé
Audi TT Coupé

Web Wrap
Contact Us : Privacy Policy : Legal Disclaimer
Copyright © Zee Media Corporation Ltd. All rights reserved